The challenges behind the promise of reimbursement
This article was originally published in Clinica
Executive Summary
From R&D to market approval, funding, clinical and cost-effectiveness assessments, cost-containment in ever tighter national and regional healthcare budgets are part of the minefield that is the medical devices and diagnostics industry. Reimbursement provides certain guarantees in an increasingly competitive and regulated environment. The issue, however, is far from simple. A new study published by Clinica Reports seeks to clarify where the industry stands in the key European and US markets